Studies were made on the isolation and identification of the Rickettsia typhi toxin-neutralizing factor (TNF) previously demonstrated in normal human serum. Although the toxicity is intimately associated with the living organisms, for purposes of discussion it has been referred to as the rickettsial "toxin." This lethal effect can be neutralized by the serum of man and lower animals convalescent from infection with these agents (11, 12) . Recently it was reported (1) that the toxin of the rickettsia of murine typhus, R. typhi, was neutralized by the serum of some normal human beings and monkeys. Thus, by means of toxin-neutralization (TN) tests in mice, 50% of 207 normal persons were found to have serum TN titers of 1: 32 or greater against R. typhi toxin. That this TN factor (TNF) was nonspecific, and not formed from exposure to R. typhi or R. prowazeki, was suggested by the prevalence of TNF in the serum of persons of all ages from widely separated localities and, particularly, by its presence in the serum of persons under 20 years of age who resided in a typhus-free area and had not received typhus vaccine. The nonspecific nature of the murine TNF was also indicated by its failure to react in complement-fixation or agglutination tests with antigens of R typhi (1).
Sephadex G-200, dextran precipitation, hydroxyapatite chromatography, and ultracentrifugation, TNF was found to be closely associated with purified serum d-lipoprotein, although no serological relationship with this protein was demonstrated. Lipase as well as trypsin digestion of purified preparations of d-lipoprotein destroyed the TN activity. No evidence was obtained for an association of TNF with the immunoglobulins or with any serum protein other than :-lipoprotein. Further studies revealed that (i) serum specimens with TN titers of 1:1024 and others with titers of 1:8 or less contained the same concentration of 3-lipoprotein; (ii) purified preparations of :-lipoprotein isolated from TNF positive and negative sera, and which had the same protein concentration, differed as much as 250-fold in TN titer; and (iii) the TN activity of a serum could be removed by absorption with antiserum to f-lipoprotein from a positive donor, but not with antiserum to :-lipoprotein from a negative donor.
A toxic reaction causing death within a few hours occurs in mice injected with yolk sacs of embryonated hens' eggs heavily infected with Rickettsia typhi or Rickettsia prowazeki (3, 11) .
Although the toxicity is intimately associated with the living organisms, for purposes of discussion it has been referred to as the rickettsial "toxin." This lethal effect can be neutralized by the serum of man and lower animals convalescent from infection with these agents (11, 12) . Recently it was reported (1) that the toxin of the rickettsia of murine typhus, R. typhi, was neutralized by the serum of some normal human beings and monkeys. Thus, by means of toxin-neutralization (TN) tests in mice, 50% of 207 normal persons were found to have serum TN titers of 1: 32 or greater against R. typhi toxin. That this TN factor (TNF) was nonspecific, and not formed from exposure to R. typhi or R. prowazeki, was suggested by the prevalence of TNF in the serum of persons of all ages from widely separated localities and, particularly, by its presence in the serum of persons under 20 years of age who resided in a typhus-free area and had not received typhus vaccine. The nonspecific nature of the murine TNF was also indicated by its failure to react in complement-fixation or agglutination tests with antigens of R typhi (1) .
The present paper reports the results of some attempts to identify and isolate this TNF from normal human serum.
MATERIALS AND METHODS Toxin-neutralization tests. The Wilmington strain of R. typhi was employed in neutralization tests conducted by a method previously described (2, 12) . In brief, serial twofold dilutions of serum or other material to be tested were made with Snyder I solution (14) , (a phosphate-buffered sucrose-glutamate solution, pH 7.2) and mixed with an equal volume of toxic suspension diluted so that each 0.5 ml of the resulting mixture contained two LD50 toxic doses. A 0.5-ml amount of each mixture was injected intravenously into each of four mice. The neutralization titer of a serum was the highest dilution that protected two or more mice. Neutralization titers are expressed as the final dilution of a serum or other material after it was mixed with a toxic suspension.
Gel filtration. A 5-ml amount of serum was applied to a Sephadex G-200 column (3 by 100 cm) which previously had been equilibrated with M/15 phos-,B-Lipoprotein preparations. Two methods were used for isolation of,-lipoprotein. First, ,B-lipoprotein was obtained from serum by precipitation with dextran sulfate (Sodium Dextran Sulfate 500, molecular weight of 5 X 105, Pharmacia, Uppsala, Sweden) by the procedure outlined by Comwell and Kruger (7). To 10 ml of serum was added 1.0 ml of 1 M calcium chloride solution and 0.2 ml of a 10% solution of dextran sulfate. After 24 hr at 4 C, the mixture was centrifuged at 5,000 X g for 10 min, and the supernatant fluid was removed. To remove certain serum proteins adhering to the sediment, the latter was dissolved in 1.0 ml of 5% sodium chloride solution and precipitated by dilution with 10 ml of 0.1 M calcium chloride. This precipitate was collected by centrifugation, and the supernatant fluid (wash 1) was saved for testing. After the precipitate was purified once more by the same procedure (wash 2), it was dissolved in 0.5 ml of 0.1 M sodium oxalate, and then 0.2 of sodium chloride and 0.25 ml of a 2% solution of protamine sulfate was added. Finally, this solution of ,B-lipoprotein was centrifuged to remove precipitated calcium oxalate and the dextran sulfate-protamine complex.
In the second method, d-lipoprotein was isolated by chromatography on hydroxyapatite columns. The hydroxyapatite was prepared as described by Tiselius et al. (17) , and chromatography was performed as described by Hjerten (13) The mixtures were incubated at 37 C for 2 hr and stored overnight at 5 C, and the precipitates were then removed by centrifugation at 2,000 X g for 30 min. The supernatant fluid from each dilution was mixed with toxin and tested in mice as described for TN tests. As a control, this same procedure was followed except that Snyder I diluent was used instead of antiserum.
Immunodiffusion analysis. Gel double-diffusion tests were conducted with 0.75% agarose (Sea Kem brand, Marine Colloids, Inc., Springfield, N.J.) dissolved in 0.9%' sodium chloride. Microscope slides (75 by 25 mm) were overlaid with 2.5 ml of the agarose solution. Wells, 2 mm in diameter with edges 4 mm apart, were filled with antigen and antibody and incubated in a humid chamber at room temperature for 24 to 48 hr.
Enzyme treatments. Preparations of ,B-lipoprotein isolated on hydroxyapatite columns and whole serum were subjected to enzymatic digestion with lipase and trypsin. Lipase (lot 448, Nutritional Biochemicals Corp., Cleveland, Ohio) solutions in 0.2 M phosphate buffer, pH 6.8, were added to the test sample to give a lipase concentration of 0.3 mg/ml of the mixture. Controls included in each test consisted of (i) test sample plus buffer, (ii) test sample plus boiled lipase, and (iii) lipase plus buffer. In addition, activity of the lipase was measured by digestion of an olive oil emulsion. The mixtures were incubated at 37 C for 4 hr, stored overnight at 5 C, and then tested for TN activity.
Trypsin (lot 4268, Nutritional Biochemicals Corp.) dissolved in M/15 PBS, pH 8.0, was added to test samples to give a trypsin concentration of 0.3 mg/ml of the mixture. Controls and test procedures were similar to those for lipase digestion except that activity of the trypsin was measured by digestion of the gelatin of a developed photographic film strip.
Ultracentrifugation. Ultracentrifugation was done in a Beckman L2-65B ultracentrifuge with an SW 50.1 rotor with swinging buckets of S ml capacity each. The solvent density of the serum was raised to 1.063 by mixing 2.5 ml of serum with 2.5 ml of a solution containing 181.7 grams of sodium chloride per liter (8) . These samples were centrifuged at 80,000 X g for 48 hr at 12 to 18 C. The layers were removed from the bottom with a hypodermic syringe and needle. Various layers were analyzed for TN titer and for certain serum proteins by gel diffusion analysis.
Microagglutination (MA) and complement-fixation (CF) tests. MA and micro CF tests were conducted as described by Fiset et al. (9, 10) . The particulate antigens for both tests consisted of a highly purified suspension of rickettsiae prepared from chicken embryo yolk sacs infected with the Wilmington strain of R. typhi (10) .
RESULTS
Sephadex G-200 gel filtration. Normal human serum with a high TN titer was separated into three major peaks (Fig. 1 ) by filtration on a Sephadex G-200 column. TN activity was found only in fractions of the first peak and, although all such fractions were active, the highest TN titers were usually found in fractions on the ascending side of this peak. The second and third peaks represented, respectively, the bulk of the IgG and albumin eluted from the column. Because serum proteins of a molecular weight greater than 200,000 are the major ones found in the first peak, these results suggested that the TN factor was either a large-molecular-weight serum protein or a substance closely associated with one. Hence, further studies to identify the TNF of normal human serum were concerned chiefly with attempts to find an association of this factor with certain of the known large-molecular-weight ser0.5-°0 (Fig. 4) .
Absorption The method of preparing :-lipoprotein for rabbit immunization had no effect on the quality of the absorbing antisera. Thus, A-lipoprotein isolated by hydroxyapatite chromatography or by precipitation with dextran sulfate produced antisera which behaved alike in absorption tests ( Table 2) .
Absorption of test sera with an antiserum to the ,B-lipoprotein of a negative donor removed most of the ,3-lipoprotein detectable by the gel diffusion test (Fig. 5) . Nevertheless, the absorbed serum retained its original TN property.
Effect of enzymes on the TNF. A-Lipoprotein isolated from sera of TNF-positive donors by hydroxyapatite chromatography was digested with lipase and with trypsin. The effect of these enzymes on the neutralizing activity of the lipoprotein preparations is shown in (5, 6) .
The mechanism by which TNF acts is clearly different from that involved in antibody neutralization of toxins or infectious agents. TNF did not agglutinate R. typhi and did not fix complement or inhibit complement fixation. Furthermore, TNF did not combine with R. typhi cells (E. J. Bell, unpublished data). TNF must, then, protect mice from rickettsial toxin by a mechanism which does not involve an antigen-antibody reaction. Further investigation on the nature of TNF may provide information on the problem of the primary site of action of the rickettsial toxin and of the mechanism by which it induces the vascular changes which result in the death of this animal.
ACKNOWLEDGMENT
The technical assistance of Earl J. Davis is gratefully acknowledged.
LITERATURE CITED
